Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CyGenica logo — Enabling SAFE, targeted and affordable intracellular deliver...

CyGenica

Enabling SAFE, targeted and affordable intracellular delivery of therapeutics for cancer and rare diseases

Founded 2017 Ireland Ireland 8 employees Seed Total: $1.40M Biotechnology

General Information

Company Name CyGenica
Founded Year 2017
Location Ireland Ireland +2
Founders / Decision Makers
Team member
Employees 8
Industries Biotechnology
Funding Stage Seed
Social

Get notified when CyGenica moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CyGenica

CyGenica is a biotechnology startup based in Ireland, founded in 2017. The company's mission, as reflected in their slogan "Enabling SAFE, targeted and affordable intracellular delivery of therapeutics for cancer and rare diseases," is to develop non-viral, non-toxic delivery solutions for drugs, gene editing components, and antibiotics. They aim to overcome the challenging issue of intracellular delivery for large molecules, particularly in gene therapy, by successfully delivering therapeutics into target cells and organelles to minimize off-target side effects and reduce the required dose. The motivation behind CyGenica's core mission is deeply personal, as the founder's father's battle with cancer led to the commitment to make cancer drugs safer and better. The company is driven by the intense desire to significantly contribute to improving the quality of life for cancer patients and others suffering from life-threatening diseases. In June 2021, CyGenica secured a noteworthy $1.40M Seed Round investment, with participation from investors including SOSV, Sharaf Yamani, Sami Mikati, VOYAGERS Health-Tech Fund, and David Rowan. With a dedicated team of academicians and professionals, CyGenica aims to become a market leader in enabling the next generation of genome editing therapeutics, with a focus on enhancing patient outcomes on a global scale. The company's commitment to making a significant impact in the field of oncology and the treatment of life-threatening diseases makes it a compelling prospect for potential investors in the biotechnology sector.

Taxonomy: Intracellular delivery, Therapeutics, Non-viral platform, Gene therapy, Cancer treatment, Rare diseases, Drug delivery system, Genome editing, Pharmaceutical industry, In vitro, In vivo, Non-toxic platform, Patient outcomes

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 5
Investor
•••• •••• 		08 Jun 2021

CyGenica Alternatives & Competitors

CyGenica vs
Ora Lee Smith Cancer Research Foundation
Ora Lee Smith Cancer Research Foundation United States

We are moving BEYOND HOPE to change the way cancer is treated!

12 employees
Health Care
CyGenica vs
Orion Therapeutics, Inc.
Orion Therapeutics, Inc. United States

Platform technology providing targeted delivery of RNA aimed at curing and preventing previously und...

7 employees
Biotechnology, Health Care

FAQ About CyGenica

Enabling SAFE, targeted and affordable intracellular delivery of therapeutics for cancer and rare diseases
CyGenica was founded in 2017.
CyGenica is headquartered in Ireland.
CyGenica operates in the following industries: Biotechnology.
CyGenica has approximately 8 employees.
CyGenica has completed 1 funding round, raising a total of $1.40M. The latest funding stage is Seed.
Top alternatives and competitors to CyGenica include Ora Lee Smith Cancer Research Foundation, Orion Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CyGenica and Ora Lee Smith Cancer Research Foundation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CyGenica and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes